Author - Ziad

14 Oct

Takeda bets up to $900M on Immusoft’s cell therapies for neurometabolic disorders

Immusoft has inked its first Big Pharma collaboration in a deal with biotech’s best friend Takeda worth up to $900 million that sees the pair work on cell therapies in rare inherited disorders. The pact will focus on neurometabolic disorders, Immusoft said Wednesday. The deal comes as the Seattle-based biotech nears the clinic for the first time in its decadelong journey working on sustained protein delivery for rare diseases. Read more >>

Portfolio News Read more...
13 Oct

FutureFuel.io Reaches New Student Debt Borrowers with Fiserv Partnership

FutureFuel.io, a technology firm that helps America’s 47.9 million borrowers crush their student loan debt, announced today a new partnership with Fiserv. This partnership will enable banks and credit unions to bring the FutureFuel.io student loan repayment platform to consumers, providing personalized, dynamic student debt management to millions of borrowers nationwide. Read more >>

Portfolio News Read more...
13 Oct

The 17 Best Dating Sites and Apps – It’s time to meet your match

There are a ton of dating apps and websites that will help you get started—Gone is the concept of swiping right or left based on looks; instead, S’more users first establish connections based on mutual interests. Each day you’ll receive recommended profiles based on your previous activity on the app (the algorithm takes into account the kind of people you swipe ‘yes’ to the most), but the matches’ photos are blurred and only become visible when you engage with […]

Portfolio News Read more...
08 Oct

Silo Pharma achieves milestone – Partner Zylo Therapeutics Receive DEA Approval to Advance Silos time released Ketamine technology

Silo Pharma, Inc. a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that their joint venture partner Zylo Therapeutics received approval from the DEA to advance the development of their Z-pod technology in combination with Ketamine. Read more >>

Portfolio News Read more...
07 Oct

American pioneers bring vision of a more inclusive, innovative and sustainable wine industry to wine2wine Business Forum

Marian Leitner-Waldman, Founder and CEO of Archer Roose, one of America’s leading canned wine producers, and Alicia Towns Franken, VP Wine Portfolio at Archer Roose, will deliver two sessions on their vision for a more inclusive and sustainable wine industry, in person at the wine2wine Business Forum in Verona on 18/19 October 2021. Franken will focus on the democratization of wine, and Leitner-Waldman will discuss on-premise wine program. Read more >>

Portfolio News Read more...
06 Oct

eSight Announces New Partnership with Merlin Entertainments to Change Lives Around The World

Leading vision-enhancement platform, eSight, announces a new partnership with Merlin Entertainments, one of the largest attractions operators in the world. Together, the companies will provide multiple life-changing experiences for individuals with vision impairment. In addition, eSight and Merlin will work together to create more inclusive initiatives for future guests with low vision or legal blindness. eSight and Merlin Entertainments are working together to create once-in-a-lifetime experiences at Merlin Entertainments’ LEGOLAND® Parks, LEGOLAND® Discovery Center and SEA LIFE locations. Read […]

Portfolio News Read more...
05 Oct

Brain injury therapy advancing toward human studies

Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug to treat brain injuries such as concussion and stroke.
The implications are enormous. A therapy for soldiers on the battlefield, car crash victims, concussed football players and people who suffer strokes could ease the pain and suffering of thousands worldwide daily and prevent debilitating long-term effects of traumatic brain injury.
Astrocyte Pharmaceuticals […]

Portfolio News Read more...
30 Sep

2021 U.S. COHORT & COMPETITION FINALISTS – MassChallenge’s 50th Accelerator Program

At MassChallenge, we support uncommon founders with an uncommon model. Our community-powered accelerator provides high-potential startups with the accountability, expertise and network they need to accelerate towards the next critical milestone. Each year, MassChallenge’s accelerator includes a competition in which startups from each cohort may compete for non-equity cash prizes. Today we are excited to announce the 45 startups that have qualified to compete in our final judging process for $1M in non-equity prizes. SCRIBLE is one of the […]

Portfolio News Read more...